Clinical Trial Update: Individualized Treatment of Hyperphosphatemia in Maintenance Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update on individualized treatment for hyperphosphatemia in maintenance hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease with Hyperphosphatemia
• Hyperphosphatemia in Maintenance Hemodialysis

Snippet

Sponsor: Chen Jing | Conditions: Maintenance Hemodialysis, Hyperphosphatemia | Phase 3 | Status: COMPLETED